EUVIMEDEUVIMED entdecken
Crossref

Enhanced In Vitro and In Vivo Autophagy Suppression via LC3 siRNA-Loaded “Smart” Nanoparticles and Doxorubicin Combination Therapy in Triple Negative Breast Cancer

Nada Walweel, Venhar Cinar, Osman Mersin, Semih Macit, Ummugulsum Yildiz, Erhan Demirel iD, Cansu Umran Tunç, Halil Ulutabanca, Zuhal Hamurcu, Yasemin Yuksel Durmaz, Omer Aydin iD

ACS Applied Bio Materials · 2025

DOI: 10.1021/acsabm.4c01778 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2025. Verfasst von Nada Walweel und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Erciyes University, Kayseri 38039, Turkey. Hauptthemen laut MEDLINE: Doxorubicin, Triple Negative Breast Neoplasms, Autophagy, Nanoparticles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: T??rkiye Bilimsel ve Teknolojik Arastirma Kurumu, T??rkiye Saglik Enstit??eri Baskanligi, T??rkiye Burslar?? (YTB).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinTriple Negative Breast NeoplasmsAutophagyNanoparticlesRNA, Small InterferingMicrotubule-Associated ProteinsBiocompatible MaterialsAntineoplastic AgentsAntibiotics, AntineoplasticHumansAnimalsMiceFemaleCell ProliferationDrug Screening Assays, AntitumorMaterials TestingParticle SizeApoptosisMice, NudeCell Line, TumorMice, Inbred BALB CDose-Response Relationship, Drug

Stichwörter der Autor:innen

LC3 siRNAartificial vectorsautophagycationic copolymersdoxorubicinsynergistic efficacytriple-negative breast cancer

Substanzen

DoxorubicinRNA, Small InterferingMicrotubule-Associated ProteinsBiocompatible MaterialsMAP1LC3A protein, humanAntineoplastic AgentsAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Erciyes University, Kayseri 38039, Turkey.
  • NanoThera Lab, ERFARMA-Drug Application and Research Center, Erciyes University, Kayseri 38280, Turkey.
  • Department of Medical Biology, Faculty of Medicine, Erciyes University, Kayseri 38030, Turkey.
  • GENKOK-Betül-Ziya Eren Genome and Stem Cell Center, Erciyes University, Kayseri 38280, Turkey.
  • Department of Biomedical Engineering, School of Engineering and Natural Sciences, Istanbul Medipol University, Istanbul 34810, Turkey.
  • Utah Center for Nanomedicine, University of Utah, Salt Lake City, Utah 84112, United States.

ORCID-Profile: Erhan Demirel, Omer Aydin

Förderung

  • T??rkiye Bilimsel ve Teknolojik Arastirma Kurumu
  • T??rkiye Saglik Enstit??eri Baskanligi
  • T??rkiye Burslar?? (YTB)
  • Bilimsel Arastirma Projeleri, Erciyes ??niversitesi

Zitieren

APA

Walweel, N., Cinar, V., Mersin, O., Macit, S., Yildiz, U., Demirel, E., Tunç, C. U., Ulutabanca, H., Hamurcu, Z., Yuksel Durmaz, Y., & Aydin, O. (2025). Enhanced In Vitro and In Vivo Autophagy Suppression via LC3 siRNA-Loaded “Smart” Nanoparticles and Doxorubicin Combination Therapy in Triple Negative Breast Cancer. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.4c01778

Vancouver

Walweel N, Cinar V, Mersin O, Macit S, Yildiz U, Demirel E, et al. Enhanced In Vitro and In Vivo Autophagy Suppression via LC3 siRNA-Loaded “Smart” Nanoparticles and Doxorubicin Combination Therapy in Triple Negative Breast Cancer. ACS Applied Bio Materials. 2025. doi:10.1021/acsabm.4c01778

BibTeX
@article{Walweel2025,
  author = {Walweel, Nada and Cinar, Venhar and Mersin, Osman and Macit, Semih and Yildiz, Ummugulsum and Demirel, Erhan and Tunç, Cansu Umran and Ulutabanca, Halil and Hamurcu, Zuhal and Yuksel Durmaz, Yasemin and Aydin, Omer},
  title = {Enhanced In Vitro and In Vivo Autophagy Suppression via LC3 siRNA-Loaded “Smart” Nanoparticles and Doxorubicin Combination Therapy in Triple Negative Breast Cancer},
  journal = {ACS Applied Bio Materials},
  year = {2025},
  doi = {10.1021/acsabm.4c01778}
}
Kostenlos starten →